NCT00269672View on ClinicalTrials.gov

Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Elderly Subjects

PHASE2CompletedINTERVENTIONAL
Enrollment

915

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

February 28, 2007

Study Completion Date

February 28, 2007

Conditions
Vaccines, Pneumococcal Conjugate Vaccine
Interventions
BIOLOGICAL

13-valent Pneumococcal Conjugate Vaccine

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00269672 - Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Elderly Subjects | Biotech Hunter | Biotech Hunter